|Videos|September 19, 2019
Danielle Andrade, MD, MSc: Education for Adult Neurologists on Pediatric-Onset Epilepsies
Author(s)Danielle Andrade, MD, MSc
The professor of medicine, neurology, at the University of Toronto discussed the best ways for adult neurologists to ensure a smooth transition of care for patients with epilepsy entering their care.
Advertisement
“One big gap that I see is that the adult neurologist’s knowledge of certain pediatric-onset epilepsies still needs some improvement, especially some genetic syndromes.”
For quite some time, the adult neurologist caring for the patient with epilepsy would encounter patients with epilepsy, but without a diagnosis, then referred to as symptomatic epilepsy. Patients would experience these diseases and undergo a number of exams, tests, and evaluations, only to fail to be properly diagnosed.
These physicians now have the good fortune of having next-generation sequencing and screenings, previously undiagnosed conditions—such as STXBP1 encephalopathy, PCDH19 epilepsy, and SCN1A mutations, to name a few—can now be addressed. New therapies and research have helped open the door for better methods of treatment.
Although, for Danielle Andrade, MD, MSc, professor of medicine, neurology, University of Toronto, who treats these pediatric patients, there is still a gap in the understanding of how to treat these childhood-onset diseases. To find out more about this gap, NeurologyLive spoke with Andrade at the 2019 International Epilepsy Congress , in Bangkok, Thailand.
For more coverage of IEC 2019, click here .
REFERENCE
Andrade D. The need for transition programs. Presented at: 2019 International Epilepsy Congress. June 22-26, 2019; Bangkok, Thailand. Presentation 71.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
2
Expanding the Alzheimer Drug Development Pipeline
3
Shared Decision-Making and Ethics in Complex Neurology Clinical Research: Paul Ford, PhD
4
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
5